LINK ALTERNATIF MBL77 - AN OVERVIEW

Not all sufferers with CLL have to have therapy. Irrespective of all new developments, the iwCLL however suggests watchful observation for individuals with asymptomatic illness.86 This recommendation is based on at the very least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituxi